Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of saxagliptin on bone metabolism in type 2 diabetes
ChiCTR-IPR-17010329Phase 4Recruiting
- Sponsor
- Nanjing First Hospital
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Saxagliptin with Placebo (2 arms). Primary endpoint: Bone mineral density. Started Jan 2017; status: recruiting.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-IPR-17010329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010329.